Search our database by keyword

Examples

Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 301 to 360 out of 360 for Apoc1

<< First < Previous | Next > Last >>

0.022s

Type

Details

Score

Strain

MGI:7608243 | (MA/MyJ x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608240 | (C57L/J x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608241 | (LG/J x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608238 | (I/LnJ x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608239 | (KK/HlJ x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608252 | (SM/J x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus))F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608253 | (SWR/J x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608250 | (SEA/GnJ x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608251 | (SJL/J x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608248 | (PL/J x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608249 | (RIIIS/J x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608246 | (NZB/BlNJ x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7608247 | (NZW/LacJ x B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus)F1

Attribute String:

F1 hybrid, transgenic

•

Strain

MGI:7606179 | B6.Cg-Tg(APOE_i3*,APOC1)2Lmh Tg(CETP)5203Tall/Lus

Attribute String:

congenic

•

Publication

37301941 | J:345431

First Author:	Kim M
Year:	2023
Journal:	Sci Rep
Title:	Integrative analysis of hepatic transcriptional profiles reveals genetic regulation of atherosclerosis in hyperlipidemic Diversity Outbred-F1 mice.
Volume:	13
Issue:	1
Pages:	9475

•

Publication

29946549 | J:290017

First Author:	Pouwer MG
Year:	2018
Journal:	Front Cardiovasc Med
Title:	The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model.
Volume:	5

Pages:	55

•

Publication

16946130 | J:128047

First Author:	Westerterp M
Year:	2006
Journal:	Arterioscler Thromb Vasc Biol
Title:	Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Volume:	26
Issue:	11
Pages:	2552-9

•

Publication

25154875 | J:217832

First Author:	Boon MR
Year:	2014
Journal:	FASEB J
Title:	Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity.
Volume:	28
Issue:	12
Pages:	5361-75

•

Publication

33658534 | J:305233

First Author:	van den Hoek AM
Year:	2021
Journal:	Sci Rep
Title:	Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men.
Volume:	11
Issue:	1
Pages:	5050

•

Publication

29975550 | J:273383

First Author:	Tarasco E
Year:	2018
Journal:	Am J Physiol Gastrointest Liver Physiol
Title:	Phenotypical heterogeneity in responder and nonresponder male ApoE*3Leiden.CETP mice.
Volume:	315
Issue:	4
Pages:	G602-G617

•

Publication

24270984 | J:209084

First Author:	Geerling JJ
Year:	2014
Journal:	Diabetes
Title:	Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice.
Volume:	63
Issue:	3
Pages:	880-91

•

Publication

36347649 | J:334213

First Author:	Liu C
Year:	2022
Journal:	Atherosclerosis
Title:	Choline and butyrate beneficially modulate the gut microbiome without affecting atherosclerosis in APOE*3-Leiden.CETP mice.
Volume:	362

Pages:	47-55

•

Publication

38060277 | J:357498

First Author:	Kurt Z
Year:	2023
Journal:	Elife
Title:	Shared and distinct pathways and networks genetically linked to coronary artery disease between human and mouse.
Volume:	12

•

Publication

17525476 | J:123774

First Author:	van der Hoogt CC
Year:	2007
Journal:	J Lipid Res
Title:	Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.
Volume:	48
Issue:	8
Pages:	1763-71

•

Publication

24473440 | J:212298

First Author:	Heemskerk MM
Year:	2014
Journal:	Am J Physiol Endocrinol Metab
Title:	Long-term niacin treatment induces insulin resistance and adrenergic responsiveness in adipocytes by adaptive downregulation of phosphodiesterase 3B.
Volume:	306
Issue:	7
Pages:	E808-13

•

Publication

31366894 | J:285993

First Author:	Schuster S
Year:	2019
Journal:	Sci Rep
Title:	Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice.
Volume:	9
Issue:	1
Pages:	11079

•

Publication

25475439 | J:264626

First Author:	van Dam AD
Year:	2015
Journal:	Diabetes
Title:	Salsalate activates brown adipose tissue in mice.
Volume:	64
Issue:	5
Pages:	1544-54

•

Publication

19150509 | J:148609

First Author:	de Haan W
Year:	2009
Journal:	Biochim Biophys Acta
Title:	PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice.
Volume:	1791
Issue:	3
Pages:	191-7

•

Publication

26694027 | J:232143

First Author:	Bennett BJ
Year:	2015
Journal:	PLoS Genet
Title:	Genetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred Strains.
Volume:	11
Issue:	12
Pages:	e1005711

•

Publication

31843957 | J:299269

First Author:	Pouwer MG
Year:	2020
Journal:	J Lipid Res
Title:	Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice.
Volume:	61
Issue:	3
Pages:	365-375

•

Publication

33567866 | J:318587

First Author:	Zhou E
Year:	2021
Journal:	Arterioscler Thromb Vasc Biol
Title:	Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice.
Volume:	41
Issue:	4
Pages:	1474-1486

•

Publication

35811030 | J:326887

First Author:	Rios-Morales M
Year:	2022
Journal:	Biochim Biophys Acta Mol Basis Dis
Title:	Butyrate oxidation attenuates the butyrate-induced improvement of insulin sensitivity in myotubes.
Volume:	1868
Issue:	11
Pages:	166476

•

Publication

18669886 | J:159800

First Author:	van der Hoorn JW
Year:	2008
Journal:	Arterioscler Thromb Vasc Biol
Title:	Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
Volume:	28
Issue:	11
Pages:	2016-22

•

Publication

21606464 | J:273485

First Author:	Wang Y
Year:	2011
Journal:	J Lipid Res
Title:	CETP expression reverses the reconstituted HDL-induced increase in VLDL.
Volume:	52
Issue:	8
Pages:	1533-41

•

Publication

17868678 | J:272541

First Author:	de Haan W
Year:	2008
Journal:	Atherosclerosis
Title:	Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
Volume:	197
Issue:	1
Pages:	57-63

•

Publication

35628290 | J:337127

First Author:	Wang F
Year:	2022
Journal:	Int J Mol Sci
Title:	Oxy210, a Semi-Synthetic Oxysterol, Exerts Anti-Inflammatory Effects in Macrophages via Inhibition of Toll-like Receptor (TLR) 4 and TLR2 Signaling and Modulation of Macrophage Polarization.
Volume:	23
Issue:	10

•

Publication

23717502 | J:200720

First Author:	Auvinen HE
Year:	2013
Journal:	PLoS One
Title:	Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.
Volume:	8
Issue:	5
Pages:	e63882

•

Publication

29038350 | J:273484

First Author:	Paalvast Y
Year:	2017
Journal:	Physiol Rep
Title:	Male apoE*3-Leiden.CETP mice on high-fat high-cholesterol diet exhibit a biphasic dyslipidemic response, mimicking the changes in plasma lipids observed through life in men.
Volume:	5
Issue:	19

•

Publication

23844130 | J:225048

First Author:	Karper JC
Year:	2013
Journal:	PLoS One
Title:	TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.
Volume:	8
Issue:	7
Pages:	e67923

•

Publication

15920036 | J:128554

First Author:	Trion A
Year:	2005
Journal:	Arterioscler Thromb Vasc Biol
Title:	No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
Volume:	25
Issue:	8
Pages:	1635-40

•

Publication

30949516 | J:290281

First Author:	Pouwer MG
Year:	2019
Journal:	J Diabetes Res
Title:	The APOE^∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis.
Volume:	2019

Pages:	9727952

•

Publication

24529136 | J:327639

First Author:	Morrison M
Year:	2014
Journal:	Atherosclerosis
Title:	Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo.
Volume:	233
Issue:	1
Pages:	149-56

•

Publication

11357474 | J:69363

First Author:	Koopmans SJ
Year:	2001
Journal:	Diabetologia
Title:	Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
Volume:	44
Issue:	4
Pages:	437-43

•

Publication

15840700 | J:117317

First Author:	Bovenschen N
Year:	2005
Journal:	Blood
Title:	LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo.
Volume:	106
Issue:	3
Pages:	906-12

•

Publication

19141870 | J:149639

First Author:	Vaessen SF
Year:	2009
Journal:	J Lipid Res
Title:	Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels.
Volume:	50
Issue:	5
Pages:	880-4

•

Publication

25258384 | J:216603

First Author:	Ason B
Year:	2014
Journal:	J Lipid Res
Title:	PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
Volume:	55
Issue:	11
Pages:	2370-9

•

Publication

25754609 | J:232977

First Author:	Berbée JF
Year:	2015
Journal:	Nat Commun
Title:	Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.
Volume:	6

Pages:	6356

•

Publication

12901842 | J:131475

First Author:	Levi O
Year:	2003
Journal:	Neurobiol Dis
Title:	ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory.
Volume:	13
Issue:	3
Pages:	273-82

•

Publication

20505312 | J:309861

First Author:	van Olffen RW
Year:	2010
Journal:	J Innate Immun
Title:	CD70-driven chronic immune activation is protective against atherosclerosis.
Volume:	2
Issue:	4
Pages:	344-52

•

Publication

24935961 | J:228420

First Author:	Calkin AC
Year:	2014
Journal:	Circ Res
Title:	Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice.
Volume:	115
Issue:	4
Pages:	442-9

•

Publication

22952318 | J:209560

First Author:	Kim JB
Year:	2012
Journal:	Circulation
Title:	Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice.
Volume:	126
Issue:	15
Pages:	1896-906

•

Publication

11090485 | J:128834

First Author:	Kliffen M
Year:	2000
Journal:	Br J Ophthalmol
Title:	The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.
Volume:	84
Issue:	12
Pages:	1415-9

•

Publication

11498466 | J:128659

First Author:	Lutgens E
Year:	2001
Journal:	Arterioscler Thromb Vasc Biol
Title:	Compensatory enlargement and stenosis develop in apoE(-/-) and apoE*3-Leiden transgenic mice.
Volume:	21
Issue:	8
Pages:	1359-65

•

Publication

11454984 | J:70488

First Author:	Mulder M
Year:	2001
Journal:	Lab Invest
Title:	Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging.
Volume:	81
Issue:	7
Pages:	953-60

•

Publication

29590620 | J:271023

First Author:	van den Berg R
Year:	2018
Journal:	Cell Rep
Title:	A Diurnal Rhythm in Brown Adipose Tissue Causes Rapid Clearance and Combustion of Plasma Lipids at Wakening.
Volume:	22
Issue:	13
Pages:	3521-3533

•

Publication

27318144 | J:239037

First Author:	Zhao L
Year:	2016
Journal:	Neurobiol Aging
Title:	Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models.
Volume:	44

Pages:	159-172

•

Publication

28422089 | J:252024

First Author:	Bartelt A
Year:	2017
Journal:	Nat Commun
Title:	Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport.
Volume:	8

Pages:	15010

•

Publication

33548499 | J:309285

First Author:	Kroon J
Year:	2021
Journal:	Mol Metab
Title:	A physiological glucocorticoid rhythm is an important regulator of brown adipose tissue function.
Volume:	47

Pages:	101179

•

Publication

19078986 | J:150224

First Author:	Jin H
Year:	2009
Journal:	J Invest Dermatol
Title:	Animal models of atopic dermatitis.
Volume:	129
Issue:	1
Pages:	31-40

•

Publication

29545368 | J:260042

First Author:	Fedoseienko A
Year:	2018
Journal:	Circ Res
Title:	COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking.

•

Questions? Comments? Click here!

MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Your name:
Your email address:
Subject:
Message:	---- Current page: ---- /mousemine/keywordSearchResults.do?searchOffset=300&searchTerm=Apoc1

MouseMine

Search our database by keyword

Examples

Search results 301 to 360 out of 360 for Apoc1

Categories

Hits by Pathway

Hits by Category

Hits by Strain